Recombinant Human FABP2 Protein，His

Fatty acid-binding protein 2 (FABP2), also known as intestinal-FABP (I-FABP), is a protein predominantly expressed in enterocytes of the small intestine, playing a crucial role in lipid metabolism and transport. The significance of FABP2/I-FABP has gained attention in recent years due to its involvement in various physiological and pathological processes, including obesity, diabetes, and metabolic syndrome. Abnormal levels of I-FABP have been associated with increased intestinal permeability and inflammation, providing insights into the pathophysiology of gastrointestinal disorders. Research on recombinant FABP2/I-FABP has been propelled by the need for better understanding of its structure-function relationships and potential therapeutic applications. Recombinant protein forms of FABP2/I-FABP allow for detailed biochemical studies and offer opportunities for developing diagnostic markers or innovative treatments targeting metabolic diseases. The expression, purification, and characterization of recombinant FABP2/I-FABP contribute to elucidating its mechanism of action, binding properties, and interactions with fatty acids and other molecules. Furthermore, the study of recombinant I-FABP can facilitate the exploration of its potential as a biomarker for intestinal injury and functionality, paving the way for novel therapeutic strategies aimed at metabolic dysregulation and related inflammatory conditions. Overall, the exploration of recombinant FABP2/I-FABP represents a promising frontier in understanding lipid metabolism and developing interventions for metabolic disorders.